Citigroup’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-282,300
| Closed | -$2.28M | – | 5571 |
|
|
2023
Q1 | $2.28M | Buy |
+282,300
| New | +$2.27M | ﹤0.01% | 1923 |
|
|
2022
Q4 | – | Sell |
-2,104,000
| Closed | -$14.6M | – | 5777 |
|
|
2022
Q3 | $14.6M | Buy |
+2,104,000
| New | +$14.6M | 0.01% | 952 |
|
|
2022
Q2 | – | Sell |
-60,200
| Closed | -$1.38M | – | 6238 |
|
|
2022
Q1 | $1.38M | Sell |
60,200
-379,700
| -86% | -$9.28M | ﹤0.01% | 2670 |
|
|
2021
Q4 | $12.2M | Buy |
439,900
+234,300
| +114% | +$6.27M | 0.01% | 1284 |
|
|
2021
Q3 | $5.73M | Buy |
+205,600
| New | +$5.83M | ﹤0.01% | 1728 |
|
|
2021
Q1 | – | Sell |
-120,500
| Closed | -$2.5M | – | 6289 |
|
|
2020
Q4 | $2.5M | Sell |
120,500
-115,800
| -49% | -$2.16M | ﹤0.01% | 2641 |
|
|
2020
Q3 | $3.66M | Buy |
236,300
+11,600
| +5% | +$200K | ﹤0.01% | 2129 |
|
|
2020
Q2 | $4.1M | Buy |
224,700
+54,200
| +32% | +$955K | ﹤0.01% | 2048 |
|
|
2020
Q1 | $2.61M | Sell |
170,500
-122,200
| -42% | -$2.95M | ﹤0.01% | 2235 |
|
|
2019
Q4 | $8.77M | Sell |
292,700
-34,900
| -11% | -$907K | 0.01% | 1597 |
|
|
2019
Q3 | $7.15M | Buy |
327,600
+3,500
| +1% | +$80.1K | 0.01% | 1643 |
|
|
2019
Q2 | $8.19M | Buy |
324,100
+123,900
| +62% | +$2.94M | 0.01% | 1548 |
|
|
2019
Q1 | $4.94M | Sell |
200,200
-289,000
| -59% | -$6.9M | ﹤0.01% | 1798 |
|
|
2018
Q4 | $9.04M | Buy |
489,200
+77,900
| +19% | +$1.85M | 0.01% | 1329 |
|
|
2018
Q3 | $10.6M | Sell |
411,300
-85,000
| -17% | -$1.95M | 0.01% | 1247 |
|
|
2018
Q2 | $11.5M | Sell |
496,300
-155,800
| -24% | -$3.22M | 0.01% | 1182 |
|
|
2018
Q1 | $10.4M | Sell |
652,100
-307,600
| -32% | -$5.73M | 0.01% | 1214 |
|
|
2017
Q4 | $20.1M | Buy |
959,700
+770,600
| +408% | +$12.2M | 0.02% | 832 |
|
|
2017
Q3 | $2.7M | Sell |
189,100
-64,700
| -25% | -$978K | ﹤0.01% | 2345 |
|
|
2017
Q2 | $4.41M | Buy |
253,800
+110,800
| +77% | +$1.33M | ﹤0.01% | 1804 |
|
|
2017
Q1 | $1.57M | Sell |
143,000
-446,600
| -76% | -$6.14M | ﹤0.01% | 2717 |
|
|
2016
Q4 | $8.56M | Sell |
589,600
-33,100
| -5% | -$607K | 0.01% | 1322 |
|
|
2016
Q3 | $15.3M | Buy |
622,700
+71,600
| +13% | +$1.85M | 0.01% | 827 |
|
|
2016
Q2 | $11.1M | Sell |
551,100
-66,700
| -11% | -$1.89M | 0.01% | 987 |
|
|
2016
Q1 | $16.3M | Buy |
617,800
+323,400
| +110% | +$23.9M | 0.02% | 710 |
|
|
2015
Q4 | $29.8M | Buy |
294,400
+207,300
| +238% | +$23.3M | 0.03% | 554 |
|
|
2015
Q3 | $15.5M | Sell |
87,100
-4,200
| -5% | -$979K | 0.01% | 849 |
|
|
2015
Q2 | $20.3M | Sell |
91,300
-26,200
| -22% | -$5.81M | 0.02% | 777 |
|
|
2015
Q1 | $23.2M | Buy |
117,500
+116,400
| +10,582% | +$20.6M | 0.02% | 691 |
|
|
2014
Q4 | $158K | Buy |
+1,100
| New | +$148K | ﹤0.01% | 4883 |
|
|
2014
Q2 | – | Sell |
-20,000
| Closed | -$2.63M | – | 7110 |
|
|
2014
Q1 | $2.63M | Buy |
+20,000
| New | +$2.73M | ﹤0.01% | 2177 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Citigroup's BHC Position: Q1 2026 in Review
Citigroup increased its Bausch Health (BHC) stake by 2.4% in Q1 2026, buying an estimated $30K and bringing the position to 210,877 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3036.
Citigroup first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.9M in Q3 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Citigroup held 210,877 shares of Bausch Health worth $1.14M as of Q1 2026.
- Citigroup bought 5,014 Bausch Health shares in Q1 2026, an estimated $30K.
- Bausch Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3036 holding.
- Citigroup first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Bausch Health position peaked at $17.9M in Q3 2015.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.